iQ3Corp. Capital Raise for iQ Series 8 Life Science Fund
ASX iQX Private Placement Announcement
40750 NSX Details of Share Registry – Change of Registry Address
40810 NSX Director Appointment Resignation – Resignation of Mr Anthony Panoyan
iQX Process to cross-list on the NASDAQ Capital Markets commenced
40023 NSX Director’s Declaration & Undertaking – Director’s Declaration – George Syrmalis
41999 NSX General Market Disclosure Other – Development of Investment Fund
40810 NSX Director Appointment Resignation – Director Appointment – George Syrmalis
40930 NSX Results of Meeting – Results of 2014 AGM
40910 NSX Notice of Annual General Meeting – 2014 IQX Notice of Annual General Meeting and Proxy
